HIND | tickerfilter.com

Fundamental analysis

38%

Profitability 35%

Dept financing 41%

Liquidity 38%

Performance 41%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-14.66%

1 Month

6.20%

3 Months

-49.21%

6 Months

-64.03%

1 Year

205.77%

2 Year

1,718.75%

Key data

Stock price

$2.91

P/E Ratio

0.00

DAY RANGE

$2.88 - $3.11

EPS

$13.55

52 WEEK RANGE

$0.30 - $16.00

52 WEEK CHANGE

$221.55

MARKET CAP

3.488 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-14-2025

BETA

1.69

PUBLIC FLOAT

AVERAGE 10 VOLUME

$92,458

AVERAGE 30 VOLUME

$187,019

Company detail

CEO: Paul F. Hickey
Region: US
Website: reshapelifesciences.com
Employees: 50
IPO year: 2016

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. Its product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes.

HIND - ReShape Lifesciences Inc.